Fractional excretion of sodium predicts worsening renal function in acute decompensated heart failure

被引:1
|
作者
Alattar, Fadi T. [1 ,2 ]
Imran, Nasha't [1 ,2 ]
DeBari, Vincent A. [2 ]
Mallah, Kozhaya N. [2 ,3 ]
Shamoon, Fayez E. [2 ,3 ]
机构
[1] Trinitas Reg Med Ctr, Dept Internal Med, Elizabeth, NJ 07207 USA
[2] Seton Hall Univ, Sch Hlth & Med Sci, Dept Internal Med, S Orange, NJ 07079 USA
[3] St Michael Med Ctr, Cardiol Dept Cardiovasc Dis, Newark, NJ USA
关键词
Diuretics; Fractional excretion of sodium (FeNa); Furosemide; Heart failure; Renal impairment; HIGH-DOSE FUROSEMIDE; SALINE SOLUTION INFUSION; LOOP DIURETICS; OUTCOMES; IMPACT; ADMISSION; BOLUS; CARE;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Renal impairment (RI), defined as an increase in creatinine level of greater than 26.5 mmol/L, develops in more than 30% of acute decompensated heart failure (ADHF) patients. Fractional excretion of sodium (FeNa) reflects sodium handling by the kidneys during diuresis. AIM: To study the relationship between FeNa and RI in patients admitted with ADHF. METHOD: The hospital course and renal function of all ADHF patients admitted to the hospital were prospectively observed. Patients were included if their admission creatinine level was 176 mmol/L or lower, they had been on a low-salt diet since admission, had urine sodium and creatinine samples collected more than 6 h after a furosemide dose in the first few days of admission, and they were on daily intravenous furosemide doses of 20 mg or more. RESULTS: Over six months, 51 patients met the inclusion criteria; the average daily dose of intravenous furosemide was 58.8 mg. RI developed in 39% of patients. A FeNa cut-off point of 0.4% was determined using ROC curve analysis; patients with a FeNa of greater than 0.4% (28 patients) were compared with patients with a lower FeNa (23 patients). Admission creatinine level and furosemide dose were higher in the first group (P=0.01 and P=0.06, respectively). The first group developed RI more frequently (OR=6.3; 95% CI 1.7 to 23.5; P=0.0047; adjusted OR for admission creatinine =6.18; 95% CI 1.6 to 24.5; P=0.0096; and adjusted OR for furosemide dose = 4.7; 95% CI 1.3 to 16.7; P=0.016). They had a longer hospitalization course (median nine days [interquartile range 6.3 to 13.5 days] versus seven days [interquartile range 4.0 to 9.0 days]; P=0.036) and they were admitted to the cardiac care unit more frequently (OR=6.8; 95% CI 1.3 to 34.9; P=0.02). CONCLUSION: A FeNa of greater than 0.4% more than 6 h after a dose of diuretics predicts RI and a complicated hospital course in ADHF patients.
引用
收藏
页码:E65 / E69
页数:5
相关论文
共 50 条
  • [1] Effect and Clinical Prediction of Worsening Renal Function in Acute Decompensated Heart Failure
    Breidthardt, Tobias
    Socrates, Thenral
    Noveanu, Markus
    Klima, Theresia
    Heinisch, Corinna
    Reichlin, Tobias
    Potocki, Mihael
    Nowak, Albina
    Tschung, Christopher
    Arenja, Nisha
    Bingisser, Roland
    Mueller, Christian
    AMERICAN JOURNAL OF CARDIOLOGY, 2011, 107 (05): : 730 - 735
  • [2] Serum alkaline phosphatase as a predictor of worsening renal function in patients with acute decompensated heart failure
    Yamazoe, Masahiro
    Mizuno, Atsushi
    Nishi, Yutaro
    Niwa, Koichiro
    Isobe, Mitsuaki
    JOURNAL OF CARDIOLOGY, 2016, 67 (5-6) : 412 - 417
  • [3] Characteristics of Patients With Improvement or Worsening in Renal Function During Treatment of Acute Decompensated Heart Failure
    Testani, Jeffrey M.
    McCauley, Brian D.
    Kimmel, Stephen E.
    Shannon, Richard P.
    AMERICAN JOURNAL OF CARDIOLOGY, 2010, 106 (12): : 1763 - 1769
  • [4] Worsening Renal Function in Patients Admitted With Acute Decompensated Heart Failure: Incidence, Risk Factors and Prognostic Implications
    Belziti, Cesar A.
    Bagnati, Rodrigo
    Ledesma, Paola
    Vulcano, Norberto
    Fernandez, Sandra
    REVISTA ESPANOLA DE CARDIOLOGIA, 2010, 63 (03): : 294 - 302
  • [5] Potential aetiologies and prognostic implications of worsening renal function in acute decompensated heart failure
    Abo-Salem, Elsayed
    Sherif, Khalid
    Dunlap, Stephanie
    Prabhakar, Sharma
    ACTA CARDIOLOGICA, 2014, 69 (06) : 657 - 663
  • [6] Association of congestion with worsening renal function in acute decompensated heart failure according to age
    Odajima, Susumu
    Fujimoto, Wataru
    Kuroda, Koji
    Yamashita, Soichiro
    Imanishi, Junichi
    Iwasaki, Masamichi
    Todoroki, Takafumi
    Okuda, Masanori
    Hayashi, Takatoshi
    Konishi, Akihide
    Shinohara, Masakazu
    Toh, Ryuji
    Hirata, Ken-ichi
    Tanaka, Hidekazu
    ESC HEART FAILURE, 2022, 9 (06): : 4250 - 4261
  • [7] Tolvaptan reduces the risk of worsening renal function in patients with acute decompensated heart failure in high-risk population
    Matsue, Yuya
    Suzuki, Makoto
    Seya, Mie
    Iwatsuka, Ryota
    Mizukami, Akira
    Nagahori, Wataru
    Ohno, Masakazu
    Matsumura, Akihiko
    Hashimoto, Yuji
    JOURNAL OF CARDIOLOGY, 2013, 61 (1-2) : 169 - 174
  • [8] The Relationship Between Transient and Persistent Worsening Renal Function and Mortality in Patients With Acute Decompensated Heart Failure
    Aronson, Doron
    Burger, Andrew J.
    JOURNAL OF CARDIAC FAILURE, 2010, 16 (07) : 541 - 547
  • [9] Worsening renal function is not associated with response to treatment in acute heart failure
    Ather, Sameer
    Bavishi, Chirag
    McCauley, Mark D.
    Dhaliwal, Amandeep
    Deswal, Anita
    Johnson, Sarah
    Chan, Wenyaw
    Aguilar, David
    Pritchett, Allison M.
    Ramasubbu, Kumudha
    Wehrens, Xander H. T.
    Bozkurt, Biykem
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 167 (05) : 1912 - 1917
  • [10] Baseline Albumin Is Associated with Worsening Renal Function in Patients with Acute Decompensated Heart Failure Receiving Continuous Infusion Loop Diuretics
    Clarke, Megan M.
    Dorsch, Michael P.
    Kim, Susie
    Aaronson, Keith D.
    Koelling, Todd M.
    Bleske, Barry E.
    PHARMACOTHERAPY, 2013, 33 (06): : 583 - 588